# Ginkgo Bioworks Holdings, Inc.: Form SCHEDULE 13D/A, filed Feb 14, 2025

- Company: [Ginkgo Bioworks Holdings, Inc.](/companies/dna.md) (CIK 1830214)
- Form: SCHEDULE 13D/A
- Filed: 2025-02-14
- Accepted by EDGAR: Feb 14, 2025, 16:03 ET
- Period: not reported
- Accession: 0001628280-25-005686
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1830214/000162828025005686/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1830214/000162828025005686/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1830214/000162828025005686/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Feb 14, 2025.
Source: SEC EDGAR, the filing index for accession 0001628280-25-005686. Last ingested by Listed: Oct 29, 2026, 16:07 ET. No prices; not investment advice.